clinical trial · NCT07073014
Long-Term Extension Study of Vosoritide to Treat Children With Hypochondroplasia
HypochondroplasiaVosoritide
brief summary
The purpose of this study is to evaluate the long-term safety and efficacy of daily doses of vosoritide in participants with HCH
started
Jun 20, 2025
primary completion
Dec 1, 2040
completion
Dec 1, 2040
last updated
Jul 18, 2025
official title
A Phase 3, Open-Label, Long-Term Extension Study to Evaluate the Safety and Efficacy of Vosoritide in Children With Hypochondroplasia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol